Evolva Holding SA
EVE | XSWX
Overview
Corporate Details
- ISIN(s):
- CH0021218067 (+1 more)
- LEI:
- 506700IF701J35J34N57
- Country:
- Switzerland
- Address:
- Duggingerstrasse 23, 4153 Reinach BL
- Website:
- https://evolva.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We are a Swiss biotech company headquartered in Reinach (Basel area) with a global network and scale. As a team of 70 employees, we live diversity and inclusion daily across geographies and the 18 nationalities of our team. We are proud of a balanced employee base with 50% of women as a strong representation of this gender within science and technology.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-04 07:00 |
Regulatory News Service
Evolva Holding SA Takes Note of GZO Shareholder Communities Announcementv
|
English | 8.1 KB | |
| 2025-06-04 02:00 |
Takeover Announcement Report
Evolva Holding SA Takes Note of GZO Shareholder Communities’ Announcementv
|
English | 6.8 KB | |
| 2025-05-27 02:00 |
Takeover Announcement Report
Evolva Holding SA announces offer to acquire GZO AG and launch a regional healt…
|
English | 10.3 KB | |
| 2024-10-29 07:00 |
Earnings Release
Evolva Holding AG publishes half-year report 2024 and IFRS annual report 2023
|
English | 10.8 KB | |
| 2024-07-15 07:00 |
Regulatory News Service
Approval of temporary exemption from certain conditions for maintaining listing…
|
English | 12.4 KB | |
| 2024-04-12 19:10 |
Delisting Announcement
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; …
|
English | 13.4 KB | |
| 2024-04-12 16:56 |
Delisting Announcement
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; …
|
English | 13.4 KB | |
| 2024-03-26 00:17 |
Regulatory News Service
Approval of temporary exemption from certain conditions for maintaining listing…
|
English | 8.0 KB | |
| 2024-03-22 07:01 |
Regulatory News Service
Evolva Holding in liquidation SA publishes liquidation interim financial statem…
|
English | 16.5 KB | |
| 2024-03-07 07:00 |
Regulatory News Service
Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be inclu…
|
English | 8.3 KB | |
| 2023-12-28 17:45 |
Takeover Announcement Report
Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 De…
|
English | 10.4 KB | |
| 2023-12-21 17:45 |
Regulatory News Service
Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary a…
|
English | 11.7 KB | |
| 2023-11-30 07:00 |
Regulatory News Service
Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to app…
|
English | 20.4 KB | |
| 2023-11-21 07:00 |
Regulatory News Service
Evolva enters into an agreement to sell its operations to Lallemand, securing t…
|
English | 18.8 KB | |
| 2023-11-14 07:00 |
Regulatory News Service
Evolva and Breko broaden partnership by signing agreement for the exclusive dis…
|
English | 11.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-23 | N/A | Executive member | Buy | None | 255,000.00 CHF |
| 2022-05-23 | N/A | Non-Executive member | Buy | None | 150,000.00 CHF |
| 2022-05-23 | N/A | Non-Executive member | Buy | None | 100,000.00 CHF |
| 2022-05-23 | N/A | Executive member | Buy | None | 70,000.00 CHF |
| 2022-05-23 | N/A | Non-Executive member | Buy | None | 60,000.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |